In
colorectal cancer, the immune response is particularly pronounced against
tumors displaying the high
microsatellite instability (MSI-H) phenotype. MSI-H
tumors accumulate mutations affecting microsatellites located within
protein encoding regions (coding microsatellites, cMS), which lead to translational shifts of the respective reading frames. Consequently, novel
tumor-specific frameshift-derived neopeptides (FSP) are generated and presented by MSI-H
tumor cells, thus eliciting effective cytotoxic immune responses. To analyze whether the immunoselective pressure was reflected by the phenotype of MSI-H
colorectal cancer cells, we compared here the expression of antigen processing machinery (APM) components and
human leukocyte antigen (HLA)
class I antigen subunits in 20 MSI-H and 20 microsatellite-stable (MSS)
colorectal cancer using a panel of newly developed APM component-specific
monoclonal antibodies. In addition, we did a systematic analysis of mutations at cMS located within APM genes and beta2-microglobulin (beta2m). Total HLA
class I antigen loss was observed in 12 (60.0%) of the 20 MSI-H lesions compared with only 6 (30.0%) of the 20 MSS
colorectal cancer lesions. Moreover, total loss of membraneous
HLA-A staining was significantly more frequent in MSI-H
colorectal cancer (P = 0.0024). Mutations at cMS of beta2m and genes encoding APM components (TAP1 and TAP2) were detected in at least 7 (35.0%) of 20 MSI-H
colorectal cancers but in none of the MSS
colorectal cancers (P = 0.0002). These data show that defects of HLA
class I antigen processing and presentation seem to be significantly more frequent in MSI-H than in MSS
colorectal cancer, suggesting that in MSI-H
colorectal cancer the immunoselective pressure leads to the outgrowth of cells with defects of antigen presentation.